Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lincare Inc.

Division of Dow Chemical Co.

Latest From Lincare Inc.

Legal News In Brief

Enzo and Illumina settle patent battle; Bard and Gore argue over jury logistics for an upcoming trial; and former employee alleges False Claims Act violations by medical equipment maker Lincare.

Legal Issues Legal Issues

What's the Difference? Sepracor's Xopenex Hit Hard by Coverage Cut

Xopenex reimbursement is being slashed by Medicare. The message: CMS wants proof of differentiation before it will pay more for line extensions and new formulations. That means trouble ahead for a lot of other products.
Reimbursement Government Payers
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dow Chemical Co.
  • Senior Management
  • James Emanuel, CFO & VP, Operations
    James T. Kelly, Pres.
  • Contact Info
  • Lincare Inc.
    Phone: (813) 576-4404
    888 Executive Drive West
    St. Petersburg, FL 33702
    USA
UsernamePublicRestriction

Register